Preventing denials before they happen: How revenue intelligence is reshaping the revenue cycle

Health systems continue to invest heavily in denial management. Yet denial volumes remain stubbornly high. The reason is simple: Most organizations are still focused on addressing denials after they occur rather than preventing them in the first place.

Roughly 15% of claims are initially denied, and hospitals spent nearly $19.7 billion in 2022 appealing denied claims. Only about half of those denials were ultimately overturned. Those numbers point to a larger problem. The real issue is not how effectively organizations manage denials; it is whether claims are submitted correctly the first time.

Denial management addresses the symptom. Denial prevention addresses the cause.

Most denials begin long before a claim submission

Denials are often viewed as a back-end revenue cycle challenge, but the root causes typically originate much earlier in the process. Research shows that approximately 90% of denials are preventable, with nearly half linked to front-end functions such as registration, eligibility verification and authorization management.

What appears as a denial at adjudication is often the result of a series of upstream breakdowns. Eligibility information may be incomplete. Authorizations may not align with payer requirements. Clinical documentation may lack the specificity needed to support coding. Coding practices may vary across teams and facilities. Each issue introduces risk that compounds as the claim moves through the revenue cycle.

By the time the claim is submitted, the outcome is often already determined. Organizations that consistently reduce denials recognize that the most effective intervention point is not after a denial is received, but before the claim is ever created.

Moving beyond reporting to revenue intelligence

For years, revenue cycle leaders have relied on retrospective reporting to understand denial performance. Monthly dashboards and denial trend reports provide visibility into what happened, but they do little to influence the outcome of claims already processed. Today’s leading organizations are moving beyond reporting and adopting a revenue intelligence approach.

Nearly half of healthcare executives identify revenue cycle operations as a top area for technology investment, reflecting growing recognition that operational visibility must be paired with action. The goal is no longer simply measuring performance. It is improving performance in real time.

Revenue intelligence connects operational, clinical and payer data to identify risks while corrective action is still possible. Instead of documenting denial patterns after the fact, organizations can identify vulnerabilities as they emerge and intervene before revenue is placed at risk.

What proactive denial prevention looks like

Effective denial prevention requires analytics to be embedded directly into revenue cycle workflows.

Claims can be evaluated before submission to identify potential denial risks and prioritize cases requiring additional review. Eligibility and benefits information can be validated at the point of service, reducing downstream corrections and rework. Authorization workflows can be monitored continuously to ensure payer requirements are satisfied before care is delivered.

Clinical documentation can also be assessed against coding and reimbursement requirements while encounters remain active, giving providers and revenue cycle teams the opportunity to address gaps before claims are finalized.

Perhaps most importantly, denial trends can be traced back to the workflows and decisions that created them. This enables organizations to identify recurring failure points, strengthen processes and continuously improve performance rather than repeatedly correcting the same issues.

The result is fewer denials, less rework and a more predictable revenue cycle.

Understanding payer behavior has become essential

As payer requirements continue to evolve, denial prevention has become increasingly dependent on understanding how individual payers behave in practice.

Prior authorization requirements continue to expand across both commercial and government programs. In Medicare Advantage alone, there were 52.8 million prior authorization determinations in 2024. Approximately 7.7% were denied, and more than 80% of those denials were eventually overturned.

These figures do not necessarily suggest inappropriate care. Instead, they highlight the growing complexity of payer requirements and the increasing importance of submission accuracy.

Organizations can no longer rely solely on contract language or static policies. Success requires visibility into historical payer behavior, denial patterns, documentation expectations and authorization requirements. The ability to identify these trends and incorporate them into daily operations is becoming a critical competitive advantage.

The financial impact of prevention

Denial prevention is often discussed as an operational initiative, but its impact extends far beyond workflow efficiency. When organizations reduce preventable denials, they decrease administrative costs, accelerate reimbursement, improve cash flow predictability and reduce the burden placed on revenue cycle staff. They also strengthen payer performance and create greater confidence in financial forecasting.

Denials can account for as much as 5% of net patient revenue loss. Preventing even a portion of that loss can have a meaningful impact on overall financial performance. More importantly, preventing denials eliminates waste throughout the revenue cycle rather than simply managing its consequences.

Stop treating denials as an inevitable cost of business

Denials are not unavoidable. They are often the result of disconnected workflows, inconsistent processes, incomplete information and missed opportunities for intervention.

Health systems that continue to focus primarily on appeals and denial resolution will remain trapped in a reactive cycle. Organizations that focus on prevention can improve claim quality, accelerate payment and create a more consistent and resilient revenue cycle.

The future of denial performance is not about responding faster after a claim is denied. It is about preventing the denial from happening at all.